Insider Stock Trading History of Dube Susan


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Dube Susan since year 2005. The trader's CIK number is 1346720. At the time of this reporting, Dube Susan is the Senior VP, Corp and of Somaxon Pharmaceuticals, Inc. . (stock ticker symbol SOMX). See this page for all insider trading activities at Somaxon Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Dube Susan since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2007-04-25 SOMX Somaxon Pharmaceuticals, Inc. Sale 14,191 15.14 214,794
2006-12-18 SOMX Somaxon Pharmaceuticals, Inc. Sale 715 15.03 10,747
2006-12-19 SOMX Somaxon Pharmaceuticals, Inc. Sale 2,246 15.00 33,692
2006-12-20 SOMX Somaxon Pharmaceuticals, Inc. Sale 1,580 15.00 23,706
2006-11-20 SOMX Somaxon Pharmaceuticals, Inc. Sale 100 15.00 1,500
2006-11-13 SOMX Somaxon Pharmaceuticals, Inc. Sale 264 15.11 3,989
2006-11-14 SOMX Somaxon Pharmaceuticals, Inc. Sale 693 15.03 10,417
2006-11-15 SOMX Somaxon Pharmaceuticals, Inc. Sale 43 15.02 645
2006-11-07 SOMX Somaxon Pharmaceuticals, Inc. Sale 50 15.00 750
2006-10-23 SOMX Somaxon Pharmaceuticals, Inc. Sale 118 15.02 1,772
2006-10-04 SOMX Somaxon Pharmaceuticals, Inc. Sale 316 12.50 3,950
2006-10-05 SOMX Somaxon Pharmaceuticals, Inc. Sale 4,581 12.57 57,574
2006-10-06 SOMX Somaxon Pharmaceuticals, Inc. Sale 11,927 13.15 156,851
2006-10-02 SOMX Somaxon Pharmaceuticals, Inc. Sale 1,975 12.62 24,926
2006-09-29 SOMX Somaxon Pharmaceuticals, Inc. Sale 601 12.54 7,538
2006-09-26 SOMX Somaxon Pharmaceuticals, Inc. Sale 600 12.62 7,573

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dube Susan (Senior VP, Corp and of Somaxon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.